Well put.
I agree with the fact that there has been years of research behind that technology. Not only that, the technology works.
I think Costanzo, Yost and management straddling the fence between Cannabix and Breathtec got VERY lucky because they had the money to invest in clinical trial process at the right time.
When insider's start to see results as patient's are tested on, the price will slowly climb for apparently no reason. It appears that may be happening already.
I dug up some of the research and will share this weekend when I have some time.
News 
Market Data 
Discover 
